VitaSpring Biomedical Co. Ltd.
Income Statement
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.8K | $75.8K | $174.5K | $135.7K | $6.1K | $69.1K | $126.5K | $117.9K |
| Operating Income | $-161.8K | $-75.8K | $-81.5K | $-135.7K | $-99.1K | $-69.1K | $-126.5K | $-117.9K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-155.8K | $-75.8K | $-81.5K | $-135.7K | $-99.1K | $-69.1K | $-126.5K | $-117.9K |
| Income Tax Expense | $0 | $0 | $0 | $6.8K | $11.8K | $11.4K | $16.6K | $78.4K |
| Net Income | $-155.8K | $-75.8K | $-81.5K | $-142.5K | $-110.8K | $-80.5K | $-143.1K | $-196.3K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 207.0M | 207.0M | 207.0M | 207.0M | 207.0M | 207.0M | 207.0M | 207.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |